Trials / Conditions / Clear Cell Sarcoma

Clear Cell Sarcoma

12 registered clinical trials studyying Clear Cell Sarcoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190	University of Florida	Phase 1 / Phase 2
Recruiting	B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3 NCT04897321	St. Jude Children's Research Hospital	Phase 1
Unknown	A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) NCT05266196	Salarius Pharmaceuticals, LLC	Phase 1 / Phase 2
Recruiting	Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Proje NCT03967834	Institut Claudius Regaud	N/A
Active Not Recruiting	B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT04483778	Seattle Children's Hospital	Phase 1
Active Not Recruiting	EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT03618381	Seattle Children's Hospital	Phase 1
Terminated	QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma NCT03132155	NantPharma, LLC	Phase 2
Unknown	Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcom NCT03600649	Salarius Pharmaceuticals, LLC	Phase 1
Unknown	Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas NCT03989596	Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2
Completed	Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors NCT02390843	Emory University	Phase 1
Completed	Molecular-Guided Therapy for Childhood Cancer NCT02162732	Giselle Sholler	N/A
Completed	Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors NCT01331135	Emory University	Phase 1